These HLA proteins as well as PLD4 and CTSS were robustly quantified with at least four peptides in the LCC cohort, and their levels were significantly elevated in PD patients (>1.7-fold; Figures 4B–4D and Table S4). This evidence concerns the gene CTSS and Parkinson disease.